Sanofi Licenses Bispecific Candidates From AI-Driven Earendil

 
• By Joseph Haas
  
Sanofi building
Sanofi's pact with Earendil is the latest in several with AI-focused firms
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Digital Technologies